Page 301 - Total War on PTSD

many months, years, or sometimes forever in order to see their symptoms reduced. Like any treatment, SSRIs approved for PTSD can have unwanted side effects, and since they are daily medications, many people struggle with them continuously.
MDMA-assisted psychotherapy uses MDMA to improve the effectiveness of psychotherapy. The treatment involves only two or three administrations of MDMA in conjunction with psychotherapy in a controlled therapeutic setting, as part of a 12-week course of psychotherapy. In this program, MDMA is not the treatment by itself, but must be administered together with psychotherapy. Once approved, patients will not be able to take the MDMA home—they won’t be filling their prescriptions at their local pharmacy. Instead, MDMA will only be available through a doctor and only in supervised therapeutic settings from certified clinicians.
MAPS has been championing and fundraising for MDMA research for 32 years and we are seeing stronger and stronger evidence that MDMA-assisted psychotherapy may be an effective treatment for PTSD, and may be a promising alternative to currently available treatment for PTSD. We intend to continue to develop and work towards approval for the treatment as diligently as we can.
NOTE: FDA Agrees to Expanded Access Program for MDMA-Assisted Psychotherapy for PTSD: https://maps.org/news/media/8008-press-release-fda-agrees-to-expanded-access- program-for-mdma-assisted-psychotherapy-for-ptsd
301 of 1042